Cat. No. 4189
Chemical Name: α,α-Diphenyl-4-[(3-pyridinylmethylene
Biological ActivitySelective Δ6 desaturase inhibitor (IC50 = 0.2 μM in vitro). Displays selectivity over Δ5 and Δ9 desaturases (IC50 values are >200 μM in vitro). Exhibits anti-inflammatory properties in a mouse edema model. Eliminates CSCs from ovarian cancer cell lines and inhibits sphere formation in vitro.
Licensing InformationSold for research purposes under agreement from Pfizer Inc.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Data Sheet
Li et al (2017) Lipid desaturation is a metabolic marker and therapeutic target of ovarian cancer stem cells. Cell Stem Cell 20 1.
Zhang et al (2010) A multiplexed cell assay in HepG2 cells for the identification of delta-5, delta-6, and delta-9 desaturase and elongase inhibitors. J.Biomol.Screen. 15 169. PMID: 20086206.
Hansen-Petrik et al (2002) Selective inhibition of delta-6 desaturase impedes intestinal tumorigenesis. Cancer Lett. 175 157. PMID: 11741743.
Obukowicz et al (1998) Novel, selective Δ6 or Δ5 fatty acid desaturase inhibitors as antiinflammatory agents in mice. J.Pharmacol.Exp.Ther. 287 157. PMID: 9765335.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products. Selected citations for SC 26196 include:
Rees et al (2016) Correlating chemical sensitivity and basal gene expression reveals mechanism of action. PLoS One 12 109. PMID: 26656090.
Do you know of a great paper that uses SC 26196 from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: SC 26196, supplier, Pfizer, SC26196, desaturases, delta6, d6, Δ6, selective, inhibitors, inhibits, anti-inflammatory, fatty, acid, metabolism, Tocris Bioscience, Other Lipid Metabolism Inhibitor products